Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - cyril+le+nouen
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Advanced Human Cell Line Technology for RSV Replication Complex Production and Antiviral Drug Discovery
This technology includes the NeurEx® mobile application, a groundbreaking tool designed for neurologists to conduct and document neurological examinations efficiently. Deployed on iPads, it integrates with a secure, cloud-based database, automating the computation of four key disability scales used in neuroimmunology. The app's robust design...
Published: 12/10/2024
|
Inventor(s):
Cyril Le Nouen
,
Joseph Marcotrigiano
,
Ursula Buchholz
,
Peter Collins
Keywords(s):
Category(s):
Application > Research Materials
,
ResearchProducts > Human Cell Lines
,
TherapeuticArea > Infectious Disease
Recombinant Chimeric Bovine/Human Parainfluenza Virus 3 Expressing SARS-CoV-2 Spike Protein and Its Use
Vaccines for SARS-CoV-2 are increasingly available under emergency use authorizations; however, indications are currently limited to individuals twelve (12) years or older. They also involve intramuscular immunization, which does not directly stimulate local immunity in the respiratory tract, the primary site of SARS-CoV-2 infection, shedding and spread....
Published: 10/28/2024
|
Inventor(s):
Shirin Munir
,
Cindy Luongo
,
Peter Collins
,
Cyril Le Nouen
,
Xueqiao Liu
,
Ursula Buchholz
Keywords(s):
2
,
ACUTE
,
Attenuated
,
B/HPIV3
,
BOVINE/HUMAN
,
chimeric
,
CORONAVIRUS
,
DC5BXX
,
DC5XXX
,
DCXXXX
,
DDXXXX
,
DEXXXX
,
DXXXXX
,
Expression
,
GLYCOPROTEIN
,
PIV3
,
respiratory
,
S
,
SARS-CoV-2
,
SEVERE
,
spike
,
Syndrome
Category(s):
Collaboration Sought > Collaboration
,
TherapeuticArea > Infectious Disease
,
Application > Vaccines
,
Application > Research Materials
Improved Live-Attenuated Vaccine for Respiratory Syncytial Virus (RSV) Bearing Codon-Pair Deoptimized NS1, NS2, N, P, M and SH Genes and Additional Point Mutations in the P Gene
RSV is the most important viral agent of severe respiratory disease in infants and young children worldwide and also causes substantial morbidity and mortality in older adults. RSV is estimated to cause more than 33 million lower respiratory tract illnesses, three million hospitalizations, and nearly 200,000 childhood deaths worldwide annually, with...
Published: 10/28/2024
|
Inventor(s):
Cyril Le Nouen
,
Ursula Buchholz
,
Peter Collins
Keywords(s):
ADDITIONAL
,
BEARING
,
Codonpair
,
DA4BXX
,
DA4XXX
,
DAXXXX
,
DC5BXX
,
DC5XXX
,
DCXXXX
,
DDXXXX
,
Deoptimized
,
DXXXXX
,
GENES
,
Improved
,
Live-Attenuated
,
M
,
Mutations
,
N
,
NS1
,
NS2
,
P
,
Pgene
,
POINT
,
respiratory
,
RSV
,
SH
,
Syncytial
,
Vaccine
,
virus
Category(s):
Collaboration Sought > Collaboration
,
Application > Research Materials
,
Application > Diagnostics
,
Application > Vaccines
,
TherapeuticArea > Infectious Disease